PL2578596T3 - Lewokarymycyna, kompozycje farmaceutyczne, sposoby otrzymywania i jej zastosowania - Google Patents

Lewokarymycyna, kompozycje farmaceutyczne, sposoby otrzymywania i jej zastosowania

Info

Publication number
PL2578596T3
PL2578596T3 PL11786088T PL11786088T PL2578596T3 PL 2578596 T3 PL2578596 T3 PL 2578596T3 PL 11786088 T PL11786088 T PL 11786088T PL 11786088 T PL11786088 T PL 11786088T PL 2578596 T3 PL2578596 T3 PL 2578596T3
Authority
PL
Poland
Prior art keywords
levocarrimycin
pharmaceutical compositions
preparation methods
preparation
methods
Prior art date
Application number
PL11786088T
Other languages
English (en)
Inventor
Yang Jiang
Yuyou Hao
Original Assignee
Shenyang Fuyang Pharmaceutical Technology Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenyang Fuyang Pharmaceutical Technology Co., Ltd. filed Critical Shenyang Fuyang Pharmaceutical Technology Co., Ltd.
Publication of PL2578596T3 publication Critical patent/PL2578596T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL11786088T 2010-05-25 2011-05-25 Lewokarymycyna, kompozycje farmaceutyczne, sposoby otrzymywania i jej zastosowania PL2578596T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201010182027 2010-05-25

Publications (1)

Publication Number Publication Date
PL2578596T3 true PL2578596T3 (pl) 2017-09-29

Family

ID=44975203

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11786088T PL2578596T3 (pl) 2010-05-25 2011-05-25 Lewokarymycyna, kompozycje farmaceutyczne, sposoby otrzymywania i jej zastosowania

Country Status (17)

Country Link
US (1) US9089586B2 (pl)
EP (1) EP2578596B1 (pl)
JP (1) JP5866737B2 (pl)
KR (2) KR101625262B1 (pl)
CN (1) CN102247396B (pl)
BR (1) BR112012029905B1 (pl)
CA (1) CA2800019C (pl)
DK (1) DK2578596T3 (pl)
ES (1) ES2633737T3 (pl)
IN (1) IN2012MN02623A (pl)
MX (1) MX346873B (pl)
MY (1) MY164230A (pl)
PH (1) PH12012502329A1 (pl)
PL (1) PL2578596T3 (pl)
RU (1) RU2593499C2 (pl)
WO (1) WO2011147316A1 (pl)
ZA (1) ZA201209739B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101706518B1 (ko) * 2010-05-25 2017-02-14 쉔양 통리엔 그룹 컴패니, 리미티드 레보이소발레릴스피라마이신 ii 또는 iii, 제제, 제조 방법 및 용도
DK2601466T3 (en) * 2010-08-04 2018-01-02 Ima Life North America Inc BULK FREEZING DURING USING SPRAY FREEZING AND DRYING UNDER STIRRING
US9945611B2 (en) 2010-08-04 2018-04-17 Ima Life North America Inc. Bulk freeze drying using spray freezing and agitated drying
CN103694295B (zh) * 2014-01-08 2016-01-20 华东理工大学 一种优化可利霉素组分的方法
CN105497053B (zh) 2015-12-31 2018-02-13 沈阳福洋医药科技有限公司 可利霉素在抗结核分枝杆菌感染中的应用
US11077126B2 (en) 2017-04-06 2021-08-03 Shenyang Fuyang Pharmaceutical Technology Co., Ltd. Use of carrimycin and pharmaceutically acceptable salts of carrimycin in manufacturing medicament for treating and/or preventing tumor
ES2912734T3 (es) * 2017-07-04 2022-05-27 Shenyang Fuyang Pharmaceutical Tech Co Ltd Uso de isovaleril espiramicina I o III en la preparación de fármaco para tratar y/o prevenir el tumor y fármaco
KR20200112898A (ko) * 2018-01-19 2020-10-05 쉔양 푸양 파마슈티컬 테크놀로지 컴퍼니 리미티드 캐리마이신 또는 이의 활성 성분의 용도
CN110051845A (zh) * 2018-01-19 2019-07-26 沈阳福洋医药科技有限公司 一种mTOR抑制剂、药物组合物及其应用
KR20200144568A (ko) * 2018-04-17 2020-12-29 상하이 통리엔 파마슈티컬 컴퍼니 리미티드 통증 및/또는 발열을 예방 및/또는 치료하는 의약품, 조합 산물 및 그 응용
CN110384710B (zh) * 2018-04-17 2023-01-10 沈阳福洋医药科技有限公司 一种用于预防和/或治疗疼痛的药物、组合产品及其应用
CN110384802B (zh) * 2018-04-17 2021-09-17 沈阳福洋医药科技有限公司 一种用于预防和/或治疗发热的药物、组合产品及其应用
CN108992416A (zh) * 2018-09-27 2018-12-14 上海同联制药有限公司 一种可利霉素肠溶片及其制备方法
WO2020228477A1 (zh) * 2019-05-16 2020-11-19 沈阳福洋医药科技有限公司 一种用于预防、缓解和/或治疗纤维化的药物、组合产品及其应用
CN112239483B (zh) * 2019-07-18 2023-10-27 沈阳福洋医药科技有限公司 一种化合物及药物组合物
CN111450066B (zh) * 2020-04-24 2022-06-21 沈阳信达泰康医药科技有限公司 一种可利霉素冻干粉针制剂及其制备方法
WO2021219112A1 (zh) * 2020-04-30 2021-11-04 沈阳福洋医药科技有限公司 异戊酰螺旋霉素类化合物或其组合物在制备治疗脓毒症疾病药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5334788A (en) * 1976-09-11 1978-03-31 Sanraku Inc Antibiotics spiramycin derivatives
CN1169947C (zh) * 2002-11-19 2004-10-06 中国医学科学院医药生物技术研究所 必特螺旋霉素的基因工程菌株螺旋霉素链霉菌wsj-195
CN1237976C (zh) * 2003-12-23 2006-01-25 沈阳同联集团有限公司 必特螺旋霉素及其在抗感染性疾病中的应用
MX2007001669A (es) * 2004-08-12 2007-04-10 Glaxosmithkline Zagreb Uso de conjugados especificos celulares para el tratamiento de enfermedades inflamatorias del tracto gastrointestinal.
KR100662363B1 (ko) * 2004-10-19 2007-01-02 엘지전자 주식회사 디스플레이 기기의 인스톨 장치 및 방법
CN101054553A (zh) * 2007-04-09 2007-10-17 中国医学科学院医药生物技术研究所 异戊酰螺旋霉素i基因工程菌株的构建
CN101649325B (zh) * 2009-07-03 2011-09-07 中国医学科学院医药生物技术研究所 一种提高基因工程异戊酰螺旋霉素主组分含量的基因串连技术
KR101706518B1 (ko) * 2010-05-25 2017-02-14 쉔양 통리엔 그룹 컴패니, 리미티드 레보이소발레릴스피라마이신 ii 또는 iii, 제제, 제조 방법 및 용도

Also Published As

Publication number Publication date
RU2012156419A (ru) 2014-06-27
MX346873B (es) 2017-03-30
CN102247396B (zh) 2014-05-28
CA2800019C (en) 2015-05-26
KR101625262B1 (ko) 2016-05-27
ES2633737T3 (es) 2017-09-25
BR112012029905B1 (pt) 2022-01-11
EP2578596B1 (en) 2017-04-19
JP5866737B2 (ja) 2016-02-17
BR112012029905A2 (pt) 2019-08-06
EP2578596A4 (en) 2013-11-06
EP2578596A1 (en) 2013-04-10
JP2013528167A (ja) 2013-07-08
KR101706519B1 (ko) 2017-02-14
IN2012MN02623A (pl) 2015-06-12
WO2011147316A1 (zh) 2011-12-01
CA2800019A1 (en) 2011-12-01
RU2593499C2 (ru) 2016-08-10
US20130150316A1 (en) 2013-06-13
CN102247396A (zh) 2011-11-23
KR20130020906A (ko) 2013-03-04
MY164230A (en) 2017-11-30
KR20160019970A (ko) 2016-02-22
MX2012013469A (es) 2013-04-03
US9089586B2 (en) 2015-07-28
PH12012502329A1 (en) 2013-02-11
ZA201209739B (en) 2014-03-26
DK2578596T3 (en) 2017-07-17

Similar Documents

Publication Publication Date Title
IL253870A0 (en) Certain amino-pyrimidines, their assemblies, and methods of using them
ZA201209739B (en) Levocarrimycin,pharmaceutical compositions,preparation methods and uses thereof
PL2562172T3 (pl) Pochodne sfelaktonu, ich kompozycje farmaceutyczne, sposoby wytwarzania i zastosowania
IL222465A0 (en) Certain amino-pyridazines, compositions thereof, and methods for their use
IL245326A0 (en) pharmaceutical preparation
IL225824A0 (en) History of quinoxaline, their preparation and pharmaceutical preparations containing them
EP2447253A4 (en) DIHYDROPYRIMIDIN COMPOUNDS AND MANUFACTURING METHOD, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
IL232577A (en) History of morpholinylbenzotriazine, their preparation and their pharmaceutical preparations
PT3210990T (pt) Levoisovalerilespiramicina iii e as suas preparações, processos para a sua preparação e as suas utilizações
EP2924042A4 (en) BIS-BETA-CARBOLINE COMPOUND AND METHOD OF MANUFACTURING, PHARMACEUTICAL COMPOSITION AND USE THEREOF
PT2504331E (pt) Composto, novas formas desse composto, composições farmacêuticas desse composto e métodos de preparação e utilização
IL228705A (en) Derivatives of Reliable Phenoxy-Ethyl, Pharmaceutical Preparations Containing and Using Them
IL230219A0 (en) History of dihydropyrazole, their preparation and pharmaceutical preparations containing them
EP2766183A4 (en) IRON FIBER COMPOSITION, PREPARATION THEREOF AND USES THEREOF
IL226554A (en) Medicinal preparations containing alisporiovir
IL225823A0 (en) History of quinazoline, their preparation and pharmaceutical preparations containing them
IL221501A (en) Medicinal product containing miramistine
GB201001911D0 (en) Pharmaceutical composition
IL225378A0 (en) History of phenylquinazoline, their preparation and pharmaceutical preparations containing them
EP2565180A4 (en) ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE PRODUCTION METHOD AND PHARMACEUTICAL COMPOSITION THEREWITH
HK1196109A (en) Iron-fiber composition, preparation and uses thereof
PL390620A1 (pl) Preparat farmaceutyczny
AU2011900931A0 (en) Pharmaceutical compositions and use thereof
GB201019775D0 (en) Pharmaceutical composition